Incidence and Risk Factors of De Novo Postpartum Hypertension
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Individuals developing hypertensive disorders of pregnancy face a 2- to 5-fold risk of long-term cardiovascular disease. Limited data exist on de novo postpartum hypertension (dnPPHTN), where those normotensive during pregnancy develop hypertension immediately postpartum. Under-recognition of dnPPHTN can lead to severe morbidity due to delayed or absent treatment and missed opportunities for mitigating long-term cardiovascular disease risk. OBJECTIVES: The aim of the study was to estimate the incidence of dnPPHTN and identify demographic and clinical risk factors for its development. METHODS: This retrospective cohort study analyzed 506 postpartum individuals delivering at a tertiary care institution over 1 month. Participants were classified as: 1) normotensive; or 2) dnPPHTN, defined as systolic blood pressure (BP) ≥140 mm Hg and/or diastolic BP ≥90 mm Hg on at least 2 occasions up to 6 weeks postpartum after a normotensive pregnancy. We excluded those with prepregnancy or antepartum hypertensive disorders. Demographic and clinical characteristics were compared using adjusted logistic regression models. RESULTS: Of 389 included participants, 35 (9.0%) developed dnPPHTN. Of these, 5.7% had pregestational diabetes compared to 0.6% of normotensive individuals (P = 0.042; adjusted OR: 11.3; 95% CI: 1.8-73.1). Early prenatal diastolic BP was higher in the dnPPHTN group (72.2 vs 68.4 mm Hg, P = 0.008), though this difference did not persist after adjustment. Medication-dependent gestational diabetes mellitus (ie, A2GDM) was associated with dnPPHTN (adjusted OR: 6.1; 95% CI: 1.2-30.1). CONCLUSIONS: Pregestational diabetes and A2GDM are associated with dnPPHTN. Closer follow-up for BP monitoring postpartum and more urgent transitions of care for ongoing medical management may reduce long-term cardiovascular risk.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Incidence and Risk Factors of De Novo Postpartum Hypertension
- Date Crossref
- 01/06/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
UC San Diego Health System pays non établi dans la noticeÉtablissement de santé
-
University of California San Diego Department of Obstetrics pays non établi dans la noticeUniversité ou école supérieure
-
Icahn School of Medicine at Mount Sinai Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Cedars-Sinai Medical Center pays non établi dans la noticeÉtablissement de santé
-
Cedars-Sinai Smidt Heart Institute Department of Cardiology pays non établi dans la noticeÉtablissement de santé
UC San Diego Health System, Department of Obstetrics — University of California San Diego et Department of Obstetrics and Gynecology — Icahn School of Medicine at Mount Sinai, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.